GR3005030T3 - - Google Patents
Info
- Publication number
- GR3005030T3 GR3005030T3 GR920401252T GR920401252T GR3005030T3 GR 3005030 T3 GR3005030 T3 GR 3005030T3 GR 920401252 T GR920401252 T GR 920401252T GR 920401252 T GR920401252 T GR 920401252T GR 3005030 T3 GR3005030 T3 GR 3005030T3
- Authority
- GR
- Greece
- Prior art keywords
- penetration
- cell
- envelope
- mixtures
- envelope disordering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93076486A | 1986-11-14 | 1986-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3005030T3 true GR3005030T3 (el) | 1993-05-24 |
Family
ID=25459727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR920401252T GR3005030T3 (el) | 1986-11-14 | 1992-06-25 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0267617B1 (el) |
JP (1) | JP2660839B2 (el) |
KR (1) | KR960001373B1 (el) |
AT (1) | ATE77559T1 (el) |
DE (1) | DE3779999T2 (el) |
ES (1) | ES2042527T3 (el) |
GR (1) | GR3005030T3 (el) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196410A (en) * | 1986-10-31 | 1993-03-23 | Pfizer Inc. | Transdermal flux enhancing compositions |
US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
US5641504A (en) * | 1988-06-09 | 1997-06-24 | Alza Corporation | Skin permeation enhancer compositions using glycerol monolinoleate |
AU611307B2 (en) * | 1988-06-09 | 1991-06-06 | Alza Corporation | Permeation enhancer comprising ethanol and glycerol monooleate |
US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
US5084267A (en) * | 1989-11-17 | 1992-01-28 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
US5262164A (en) * | 1989-11-17 | 1993-11-16 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
US5096715A (en) * | 1989-11-20 | 1992-03-17 | Alko Ltd. | Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist |
US5374645A (en) * | 1990-01-22 | 1994-12-20 | Ciba-Geigy Corporation | Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol |
US5149719A (en) * | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
PT100502A (pt) * | 1991-05-20 | 1993-08-31 | Alza Corp | Composicoes farmaceuticas para aumentar a capacidade de permeacao na pele utilizando monolinoleato de glicerol |
AU6410494A (en) * | 1993-03-17 | 1994-10-11 | Alza Corporation | Device for the transdermal administration of alprazolam |
HU214582B (hu) * | 1994-07-26 | 1998-04-28 | EGIS Gyógyszergyár Rt. | Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására |
US5861439A (en) * | 1994-11-14 | 1999-01-19 | Alza Corporation | Method for enhanced electrotransport agent delivery |
CA2181364A1 (en) * | 1994-11-17 | 1996-05-30 | Kaneto Uekama | Preparation for percutaneous absorption |
JP2001502317A (ja) * | 1996-10-16 | 2001-02-20 | アイ・ピー・アール・インシティチュート・フォー・ファーマシューティカル・リサーチ・エー・ジー | 新規なキャリヤー系 |
NZ502569A (en) * | 1997-07-29 | 2002-05-31 | Upjohn Co | Self-emulsifying formulation for lipophilic compounds comprising a mixture of diglyceride and monoglyceride in a ratio of 9:1 to 6:4 |
JP5005847B2 (ja) * | 1997-07-29 | 2012-08-22 | ベーリンガー・インゲルハイム・インテルナツィオナール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 親油性化合物用の自己乳化性処方 |
DE69840426D1 (de) * | 1997-11-10 | 2009-02-12 | Strakan Int Ltd | Penetrationsfördernde und irritationsvermindernde Systeme mit Testosteron |
JP2002516828A (ja) * | 1998-06-01 | 2002-06-11 | アンソニー・ジェイ・バービスカー | 局所経皮治療 |
US7074803B2 (en) * | 2001-03-02 | 2006-07-11 | Durect Corporation | Opioid formulations |
US7179483B2 (en) | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
IT1318705B1 (it) * | 2000-09-22 | 2003-08-27 | Gianluigi Ciocca | Medicamento transdermico ad alta penetrazione. |
KR20040002890A (ko) * | 2001-05-31 | 2004-01-07 | 히사미쓰 세이야꾸 가부시키가이샤 | 경피흡수형 첩부제 |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
PL1670433T3 (pl) | 2003-10-10 | 2013-03-29 | Ferring Bv | Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze |
WO2007124250A2 (en) | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
FR2905601A1 (fr) * | 2006-09-11 | 2008-03-14 | Innoderm Sarl | Utilisation de derives oleiques comme methode et composition favorisant la penetration cutanee des actifs contenus dans les compositions cosmetiques, pharmaceutiques ou dermatologiques. |
US8927537B2 (en) * | 2007-12-21 | 2015-01-06 | Nuvo Research Inc. | Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
JP5619363B2 (ja) * | 2008-03-03 | 2014-11-05 | ニプロパッチ株式会社 | 経皮吸収促進剤、並びにこれを含有する皮膚処理用製剤及び経皮吸収型製剤 |
CA2926736C (en) * | 2013-11-05 | 2023-02-28 | 3M Innovative Properties Company | Injectable antineoplastic formilations comprising sesame oil and an immune response modifier |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0095813A3 (en) * | 1982-06-01 | 1985-05-08 | THE PROCTER & GAMBLE COMPANY | Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine |
DE3233638A1 (de) * | 1982-09-10 | 1984-03-15 | Thilo & Co Gmbh Dr | Dermatologische zubereitung |
US4537776A (en) * | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
US4637930A (en) * | 1984-02-08 | 1987-01-20 | Yamanouchi Pharmaceutical Co, Ltd. | Transdermal formulation of nicardipine hydrochloride |
US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
JPH0764754B2 (ja) * | 1984-10-02 | 1995-07-12 | 花王株式会社 | 経皮吸収促進剤及びこれを含有する皮膚外用剤 |
JPS6185332A (ja) * | 1984-10-04 | 1986-04-30 | Kao Corp | 経粘膜吸収促進剤及びこれを含有する経粘膜投与用製剤 |
-
1987
- 1987-11-12 DE DE8787116733T patent/DE3779999T2/de not_active Expired - Lifetime
- 1987-11-12 AT AT87116733T patent/ATE77559T1/de not_active IP Right Cessation
- 1987-11-12 EP EP87116733A patent/EP0267617B1/en not_active Expired - Lifetime
- 1987-11-12 ES ES87116733T patent/ES2042527T3/es not_active Expired - Lifetime
- 1987-11-13 JP JP62285677A patent/JP2660839B2/ja not_active Expired - Lifetime
- 1987-11-14 KR KR1019870012875A patent/KR960001373B1/ko not_active IP Right Cessation
-
1992
- 1992-06-25 GR GR920401252T patent/GR3005030T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0267617B1 (en) | 1992-06-24 |
ES2042527T3 (es) | 1993-12-16 |
JP2660839B2 (ja) | 1997-10-08 |
EP0267617A1 (en) | 1988-05-18 |
JPS63211241A (ja) | 1988-09-02 |
ATE77559T1 (de) | 1992-07-15 |
KR960001373B1 (ko) | 1996-01-26 |
KR880005939A (ko) | 1988-07-21 |
DE3779999D1 (de) | 1992-07-30 |
DE3779999T2 (de) | 1992-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3005030T3 (el) | ||
US4789667A (en) | External pharmaceutical composition and methods of use | |
EP0261429B1 (en) | Penetration enhancement systems and the preparation thereof | |
CA1223819A (en) | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one | |
Santoyo et al. | Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin | |
AU601423B2 (en) | Dual phase solvent carrier system | |
US4537776A (en) | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone | |
US4954487A (en) | Penetrating topical pharmaceutical compositions | |
CA1293192C (en) | Compositions comprising 1-substituted azacycloalkanes | |
MY101536A (en) | Anti-inflammatory and analgesic tape for external use | |
KR900004330A (ko) | 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법 | |
AUPP310798A0 (en) | Vehicle system for a composition comprising a piperidinopyrimidine derivative | |
GB2153223A (en) | Composition for percutaneously administering metoclopramide | |
US5438067A (en) | Medetomidine preparations for transdermal administration | |
EP0317959A3 (en) | Anti-ulcer composition | |
CA1200497A (en) | Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine | |
US4863952A (en) | Method of promoting percutaneous drug absorption with 2-pyrrolidin-2-one 5-carboxylic acids and esters thereof | |
AU658487B2 (en) | Transdermal compositions | |
US4923875A (en) | Method for treatment of mast cell-mediated dermatologic disorders | |
EP0535237A4 (en) | Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same | |
IE791995L (en) | Formulation | |
EP0267051B1 (en) | Transdermal administration of amines | |
EP0255485A2 (en) | Transdermal compositions | |
IL74421A (en) | Dermatological antifungal aerosol compositions containing phenylalkoxyaralkyl imidazole derivatives | |
IE38967L (en) | 16-cyano-pregnene compounds. |